[go: up one dir, main page]

AU2001248769A1 - Time-release coated solid compositions for oral administration - Google Patents

Time-release coated solid compositions for oral administration

Info

Publication number
AU2001248769A1
AU2001248769A1 AU2001248769A AU4876901A AU2001248769A1 AU 2001248769 A1 AU2001248769 A1 AU 2001248769A1 AU 2001248769 A AU2001248769 A AU 2001248769A AU 4876901 A AU4876901 A AU 4876901A AU 2001248769 A1 AU2001248769 A1 AU 2001248769A1
Authority
AU
Australia
Prior art keywords
time
oral administration
solid compositions
release coated
coated solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248769A
Inventor
Kazuhiro Sako
Toyohiro Sawada
Shunsuke Watanabe
Tatsunobu Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU2001248769A1 publication Critical patent/AU2001248769A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001248769A 2000-04-17 2001-04-16 Time-release coated solid compositions for oral administration Abandoned AU2001248769A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19808600P 2000-04-17 2000-04-17
US60198086 2000-04-17
PCT/JP2001/003229 WO2001078686A1 (en) 2000-04-17 2001-04-16 Time-release coated solid compositions for oral administration

Publications (1)

Publication Number Publication Date
AU2001248769A1 true AU2001248769A1 (en) 2001-10-30

Family

ID=22731930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248769A Abandoned AU2001248769A1 (en) 2000-04-17 2001-04-16 Time-release coated solid compositions for oral administration

Country Status (4)

Country Link
US (2) US20020028240A1 (en)
EP (1) EP1275381A4 (en)
AU (1) AU2001248769A1 (en)
WO (1) WO2001078686A1 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
US20080199522A1 (en) * 2001-04-12 2008-08-21 Astellas Pharma, Inc. Timed-release compression-coated solid composition for oral administration
US7217381B2 (en) * 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US20030229158A1 (en) * 2001-09-28 2003-12-11 Chen Jen Chi Polymer composition and dosage forms comprising the same
EP1429745A2 (en) * 2001-09-28 2004-06-23 McNEIL-PPC, INC. Composite dosage forms having an inlaid portion
US6982094B2 (en) * 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
JP4513007B2 (en) * 2002-09-26 2010-07-28 アステラス製薬株式会社 Drug absorption improver
US20040081695A1 (en) * 2002-09-28 2004-04-29 Sowden Harry S Dosage forms having an inner core and an outer shell
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
AU2003301762B2 (en) * 2002-10-25 2006-02-09 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
JP4790597B2 (en) 2003-04-24 2011-10-12 ヤゴテック アーゲー Delayed release tablets with defined core geometry
PL1663216T3 (en) 2003-08-29 2012-03-30 Veloxis Pharmaceuticals As Modified release compositions comprising tacrolimus
CN1859909B (en) * 2003-08-29 2011-04-06 生命周期药物公司 Solid dispersions comprising tacrolimus
MXPA06003101A (en) * 2003-09-19 2006-06-20 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms.
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
MXPA06006677A (en) * 2003-12-12 2006-08-31 Penwest Pharmaceuticals Co Sustained release torsemide dosage forms.
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
KR100598326B1 (en) * 2004-04-10 2006-07-10 한미약품 주식회사 Sustained-release preparations for oral administration of a HMVII-COA reductase inhibitor and preparation method thereof
DE102004043863A1 (en) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tablets with local and time-controlled drug release in the gastrointestinal tract
CA2579732C (en) * 2004-09-10 2014-08-12 Nitec Pharma Ag Tablets with site time-controlled gastrointestinal release of active ingredient
BRPI0516468A (en) * 2004-10-05 2008-09-09 Astellas Pharma Inc pharmaceutical composition for the treatment of xerophthalmia and xerostomia
WO2006042277A2 (en) * 2004-10-12 2006-04-20 Eisai R&D Management Co., Ltd. Extended release compositions of proton pump inhibitors
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060275513A1 (en) * 2005-06-07 2006-12-07 Gardiner Paul T Diet supplement for burning additional calories, providing sustained energy, supporting weight loss, and/or improving mental focus
DE202006002409U1 (en) 2006-01-18 2006-04-20 Gottlieb Binder Gmbh & Co. Kg Flame retardant closure
WO2007092026A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Dipyridamole extended-release formulations and process for preparing same
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US20080075768A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophobic opioid abuse deterrent delivery system using opioid antagonists
DK2049123T4 (en) 2006-08-03 2016-11-28 Horizon Pharma Ag LATE discharge-glucocorticoid treatment of rheumatoid ILLNESS
WO2008023869A1 (en) * 2006-08-24 2008-02-28 Hanall Pharmaceutical Co., Ltd. Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
US20080241240A1 (en) * 2006-08-24 2008-10-02 Hanall Pharmaceutical Co., Ltd. Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
JPWO2008081829A1 (en) 2006-12-27 2010-04-30 アステラス製薬株式会社 Aminoalkyl methacrylate copolymer E for maintaining solubility of poorly water-soluble drugs
JPWO2008084698A1 (en) * 2006-12-28 2010-04-30 アステラス製薬株式会社 Tacrolimus sustained-release pharmaceutical composition
US20080249178A1 (en) 2007-03-22 2008-10-09 Guosong Liu Magnesium compositions and uses thereof for increasing lifespan
NZ599300A (en) 2007-03-22 2014-04-30 Magceutics Inc Magnesium compositions and uses thereof
PL2167033T4 (en) 2007-05-30 2018-08-31 Veloxis Pharmaceuticals A/S Once daily oral dosage form comprising tacrolimus
US12083103B2 (en) 2007-05-30 2024-09-10 Veloxis Pharmaceuticals, Inc. Tacrolimus for improved treatment of transplant patients
US12403095B2 (en) 2008-05-30 2025-09-02 Veloxis Pharmaceuticals, Inc. Stabilized tacrolimus composition
CN102573496B (en) * 2009-07-01 2015-08-26 玛格塞蒂克斯公司 Slow release magnesium composition and uses thereof
US20110046227A1 (en) * 2009-08-21 2011-02-24 Mutual Pharmaceutical Company, Inc. Methods for concomitant administration of colchicine and a second active agent
PL2575769T3 (en) * 2010-02-17 2016-12-30 Stabilized tacrolimus composition
CN104873455B (en) 2010-12-22 2023-09-12 普渡制药公司 Coated Tamper Resistant Controlled Release Dosage Forms
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
US20130045273A1 (en) * 2011-08-19 2013-02-21 John Cuomo Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds
SG11201506064UA (en) 2013-02-05 2015-08-28 Purdue Pharma Lp Tamper resistant pharmaceutical formulations
PT2959892T (en) * 2013-02-22 2020-12-15 Zeria Pharm Co Ltd Enteric coated tablet
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
WO2017018473A1 (en) * 2015-07-30 2017-02-02 武田薬品工業株式会社 Tablet
AU2018210141A1 (en) * 2017-01-20 2019-08-29 Constellation Pharmaceuticals, Inc. Solid dispersions of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
WO2018200885A1 (en) 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB986254A (en) * 1962-12-11 1965-03-17 Upjohn Co Coated tablets
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
ES2106818T3 (en) * 1991-10-30 1997-11-16 Glaxo Group Ltd MULTILAYER COMPOSITION CONTAINING HISTAMINE OR SECOTIN ANTAGONISTS.
CZ291495B6 (en) * 1992-09-18 2003-03-12 Yamanouchi Pharmaceutical Co., Ltd. Prolonged release hydrogel pharmaceutical preparation
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US5931381A (en) * 1997-05-23 1999-08-03 Fiedrich; Joachim For radiant floor, wall and ceiling hydronic heating and/or cooling systems using metal plates that are heated or cooled by attached tubing that is fed hot or cold water, techniques of improving performance and avoiding condensation when cooling
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
US6248359B1 (en) * 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US6277409B1 (en) * 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
US20080199522A1 (en) * 2001-04-12 2008-08-21 Astellas Pharma, Inc. Timed-release compression-coated solid composition for oral administration

Also Published As

Publication number Publication date
EP1275381A4 (en) 2007-05-02
EP1275381A1 (en) 2003-01-15
US20060292221A1 (en) 2006-12-28
US20020028240A1 (en) 2002-03-07
WO2001078686A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2001248769A1 (en) Time-release coated solid compositions for oral administration
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2276801A (en) Extended release oral dosage composition
AU2001274307A1 (en) Pharmaceutical compositions
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU2277101A (en) Stable extended release oral dosage composition
AU2115301A (en) Dental compositions
AU3192700A (en) Medicinal compositions
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU4428000A (en) Pulse-delivery oral compositions
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001225164A1 (en) Compositions with enhanced oral bioavailability
AU2001273919A1 (en) Pharmaceutical compositions
AU6460400A (en) Pharmaceutical compositions
AU2002210433A1 (en) Dental compositions
AU1732401A (en) Medicinal compositions for oral use
AU2001270235A1 (en) Oral compositions
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU6460200A (en) Pharmaceutical compositions
AU4085201A (en) Pharmaceutical composition
AU2001290669A1 (en) Oral compositions
AU6460100A (en) Pharmaceutical compositions